Evaluating Stromal Vascular Fraction As a Treatment for Peripheral Nerve Regeneration: A Scoping Review
Journal of Oral and Maxillofacial Surgery · 2024
DOI: 10.1016/j.joms.2024.03.024 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Oral and Maxillofacial Surgery, 2024. Verfasst von Tyler Jacobs und 3 weiteren Autor:innen. Beteiligte Einrichtung: Resident, Department of Oral and Maxillofacial Surgery, Rutgers School of Dental Medicine, Newark, NJ. Electronic address: tbj15@sdm.rutgers.edu. Hauptthemen laut MEDLINE: Nerve Regeneration. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This study aims to investigate the potential of stromal vascular fraction (SVF) for peripheral nerve regeneration. METHODS: A scoping review of Scopus and PubMed databases was conducted. Inclusion criteria were human or animal studies exploring the use of SVF for peripheral nerve regeneration. Studies were categorized by assessed outcomes: pain assessment, neural integrity, muscle recovery, and functional recovery. Level of evidence and study quality were assessed. RESULTS: Nine studies met the inclusion criteria. SVF injection in humans with trigeminal neuropathic pain reduced pain scores from 7.5 ± 1.58 to 4.3 ± 3.28. SVF injection improved sensation in humans with leprosy neuropathy. Repairing transected rat sciatic nerves with SVF-coated nerve autografts improved wet muscle weight ratios (0.65 ± 0.11 vs 0.55 ± 0.06) and sciatic functional index (SFI) scores (-68.2 ± 9.2 vs -72.5 ± 8.9). Repairing transected rat sciatic nerves with SVF-coated conduits increased the ratio of gastrocnemius muscle weights (RGMW) (7-10% improvement), myelinated fibers (1,605 ± 806.2 vs 543.6 ± 478.66), and myelin thickness (5-20% increase). Repairing transected rat facial nerves with SVF-coated conduits improved whisker motion (9.22° ± 0.65° vs 1.90° ± 0.84°) and myelin thickness (0.57 μm ± 0.17 vs 0.45 μm ± 0.14 μm). Repairing transected rat sciatic nerves with SVF-coated nerve allografts improved RGMW (85 vs 50%), SFI scores (-20 to -10 vs -40 to -30), and Basso, Beatie, and Bresnahan locomotor scores (18 vs 15). All metrics mentioned above were statistically significant. The human studies were level 4 evidence due to being case series, while animal studies were the lowest level of evidence. CONCLUSION: Despite initial promising results, the low-level evidence from the included studies warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Resident, Department of Oral and Maxillofacial Surgery, Rutgers School of Dental Medicine, Newark, NJ. Electronic address: tbj15@sdm.rutgers.edu.
- Private Practice, Monticello, MN.
- B.A. Candidate, New Jersey Institute of Technology, Newark, NJ.
- Professor, Chair, and Associate Dean for Hospital Affairs, Department of Oral and Maxillofacial Surgery, Rutgers School of Dental Medicine, Newark, NJ.
Zitieren
APA
Jacobs, T., Mahoney, C., Mohammed, S., & Ziccardi, V. (2024). Evaluating Stromal Vascular Fraction As a Treatment for Peripheral Nerve Regeneration: A Scoping Review. Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.joms.2024.03.024
Vancouver
Jacobs T, Mahoney C, Mohammed S, Ziccardi V. Evaluating Stromal Vascular Fraction As a Treatment for Peripheral Nerve Regeneration: A Scoping Review. Journal of Oral and Maxillofacial Surgery. 2024. doi:10.1016/j.joms.2024.03.024
BibTeX
@article{Jacobs2024,
author = {Jacobs, Tyler and Mahoney, Connor and Mohammed, Saad and Ziccardi, Vincent},
title = {Evaluating Stromal Vascular Fraction As a Treatment for Peripheral Nerve Regeneration: A Scoping Review},
journal = {Journal of Oral and Maxillofacial Surgery},
year = {2024},
doi = {10.1016/j.joms.2024.03.024}
}
EUVIMED